Bowel preparation protocols appeared protective in small study
Also in TTHealthWatch: AACR report on cancer
Researchers highlight semaglutide's potential value for preventing overdoses
The three companies process about 80% of prescriptions in the U.S.
Drugmaker none-too-pleased with agency's request for additional studies
Health news and commentary gathered by MedPage Today staff
Limited benefit seen in patients with established cirrhosis, however
Researcher discusses weight outcomes for those taking semaglutide or liraglutide
More noteworthy research from the EASD 2024 meeting
Three-day intervention boosted time spent in normal glucose range
Regulators will need to closely watch this new frontier
Relationship was mediated by comorbid dyslipidemia
But higher severe hypoglycemia risk with efsitora in type 1 diabetes likely precludes its use